Glossary · Documentation

Specimens / pathology sent

Specimens or pathology sent refers to the documentation of any tissue, bone, fluid, or other biological material removed during an orthopedic procedure and forwarded to a pathology laboratory for gross or microscopic analysis. Accurate documentation of each specimen—by anatomical site, laterality, and type—is required to support both the surgical CPT code and the pathology CPT code billed downstream.

Verified May 8, 2026 · 7 sources ↓

Drawn from AnnexmedMedusindCMSAdscAAOS

Definition

Source · Editorial summary grounded in 7 cited references ↓

When an orthopedic surgeon removes tissue during a procedure—a bone biopsy, synovial membrane, meniscal fragment, or excised soft-tissue mass—that material becomes a billable specimen the moment it leaves the operative field for pathology review. The operative note must identify each specimen by its exact anatomical origin (e.g., 'right knee medial meniscus, posterior horn'), whether it was sent fresh, in formalin, or frozen, and what clinical question the pathologist is being asked to answer. These details map directly to the surgical pathology CPT tier (88300–88309), where reimbursement escalates with specimen complexity and the degree of microscopic examination performed.

From a coding perspective, specimens sent create a two-claim event: the surgeon bills for the procedure that generated the specimen, and the pathologist (or the hospital lab) bills separately for the examination. If the operative note names the specimen imprecisely—'biopsy' rather than 'femur, biopsy' or 'bone tumor resection'—the pathology lab may assign a lower-complexity CPT code than the work actually performed, or the surgeon's claim may lack the ICD-10 specificity to establish medical necessity for the resection itself.

For orthopedic practices, the specimen documentation line in the operative report is also a compliance checkpoint. Payers and auditors cross-reference the surgeon's operative note against the pathology report. A specimen listed in billing records that does not appear in either document is a red flag for overpayment review. Conversely, tissue sent to pathology but not recorded in the operative note creates a documentation gap that can unravel a claim post-payment.

Why it matters

Incomplete or vague specimen documentation produces a chain of downstream problems: the pathology lab cannot assign the correct 88300-series CPT level without a precise specimen description, reducing reimbursement for the lab; the surgeon's claim may be denied or downcoded if the ICD-10 diagnosis lacks the specificity that the submitted pathology CPT code implies; and in a post-payment audit, a mismatch between what the operative note records as 'sent to pathology' and what the pathology report actually describes is treated as a documentation deficiency that can trigger recoupment of both the surgical fee and the pathology fee.

Common mistakes

Where people most often go wrong with this concept.

Source · Editorial brief grounded in cited references ↓

  • Listing the specimen generically as 'tissue' or 'biopsy' rather than naming the exact anatomical site and laterality, which prevents the pathology lab from selecting the highest-supported CPT tier under 88300–88309.
  • Failing to document laterality for paired structures (e.g., 'knee synovium' instead of 'left knee synovium'), which creates a mismatch when the surgical CPT code carries a laterality modifier and the pathology note does not.
  • Omitting specimens from the operative note when they are sent intraoperatively as frozen sections, then only documenting the permanent specimen—leaving the frozen-section pathology charge unsupported.
  • Using a sign-or-symptom ICD-10 code (e.g., nonspecific knee pain) as the diagnosis on a claim that also bills a high-complexity pathology CPT code for a tumor resection, signaling a medical-necessity mismatch to payers.
  • Assuming that routine arthroscopic debris or lavage fluid does not require documentation notation; if any tissue is sent, it must be recorded—failure to do so makes the resulting pathology charge appear unsupported.
  • Not reconciling the specimen count in the operative note with the number of specimen jars logged by the circulating nurse; a numeric discrepancy is an audit trigger.

Related codes

Codes commonly involved when this concept appears in practice.

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 7 cited references ↓

01Does every specimen sent to pathology require its own CPT code?
Generally yes. Surgical pathology CPT codes 88300–88309 are reported per specimen, with the code level determined by the complexity of examination for that specific specimen. If two anatomically distinct specimens are sent—say, a synovial biopsy and a bone chip—each is coded to its appropriate level. Always confirm with your MAC's specimen-to-level table, as some tissues have defined default levels.
02What ICD-10 code should the surgeon use when tissue is sent to pathology but the diagnosis is not yet confirmed?
When the pathologic diagnosis is pending at the time of the surgeon's claim submission, use the sign, symptom, or finding that prompted the procedure (e.g., a mass, pain, or radiographic abnormality). Do not speculate by coding a confirmed malignancy before the pathology report returns. Once the final pathology result is available, amended coding may be needed for any subsequent encounter.
03Who bills for the pathology—the surgeon or the pathologist?
In most cases, the pathologist or the laboratory bills for the 88300-series examination. If the surgeon personally examines and interprets the specimen and generates a separate written report, the surgeon may bill the professional component (modifier 26). The technical component (modifier TC) goes to the entity that performed the lab work. Surgeons who simply send tissue to an outside lab do not bill any pathology CPT code for that specimen.
04Can the same specimen be billed under both the surgical CPT code and a pathology CPT code?
Yes, and this is expected. The surgical CPT code (e.g., an arthroscopic meniscectomy) covers the procedure that generated the specimen. The pathology CPT code (e.g., 88305) covers the examination of the tissue after removal. These are separate services performed by different providers or departments and are billed on separate claims. They are not considered duplicate billing.
05What happens if the operative note says a specimen was sent but there is no corresponding pathology report?
A pathology CPT code billed without a matching pathology report is unsupported and will be recouped in an audit. If the specimen was sent but the report has not yet been finalized, hold the pathology claim until the report is available. If the specimen was lost or never processed, document that fact in the medical record and do not bill for the examination.

Mira AI Scribe

When Mira detects that an operative note includes removal of tissue, bone, or fluid, it prompts the surgeon to confirm and document each specimen with: (1) the precise anatomical site and laterality, (2) the specimen type (e.g., synovial membrane, meniscal fragment, bone core), (3) the preservation method (formalin, fresh, frozen), and (4) the clinical indication driving pathology review. Mira then surfaces the corresponding surgical pathology CPT tier (88300–88309) appropriate to the specimen description, flags any mismatch between the operative ICD-10 diagnosis code and the complexity level of pathology being ordered, and alerts the coder if the specimen count in the note differs from the number of jar entries logged. For cases where the surgeon performs only the professional component of pathology review—such as intraoperative frozen-section interpretation—Mira will append modifier 26 to the pathology CPT and suppress the TC. Where specimens are sent to an outside reference lab, Mira flags the case for split-billing review so that neither the originating lab nor the consulting lab double-bills stains or preparation codes. These automations reduce the most common specimen documentation deficiencies that drive pathology claim denials and post-payment audit exposure in orthopedic practices.

See Mira's approach

Related terms

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free